Download Files:
Zurletrectinib
SKU
HY-148811-Get quote
Category Reference compound
Tags c-Met/HGFR, Cancer, Protein Tyrosine Kinase/RTK
Products Details
Product Description
– Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of preventing TRK-mediated related diseases, such as tumors[1][2].
Web ID
– HY-148811
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C19H19F2N7O2
References
– [1]WHO Drug Information-World Health Organization (WHO).|[2]Kong NX, et al. Preparation of the heterocyclic compounds as trk inhibitor: World Intellectual Property Organization, WO2020001415. 2020-01-02.
CAS Number
– 2403703-30-8
Molecular Weight
– 415.40
SMILES
– O=C1NC2=C3N=C(N4[C@@](C[C@@](F)([H])C4)([H])C5=CC(F)=CN=C5O[C@](C)([H])CN1)C=CN3N=C2
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– c-Met/HGFR
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.